SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " rio " 43,466 found 🔀 AI-powered Shuffle
Accel Entertainment (ACEL) Expands Louisiana Gaming Footprint Through Truck Stop Casino Acquisition
Accel Entertainment, Inc. (NYSE:ACEL) ranks among the best sin stocks to buy for recession protection. On June 3, Accel Entertainment, Inc. (NYSE:ACEL) strengthened its Louisiana business with the acquisition of Rice Palace Truck Stop Casino in Crowley, adding a high-volume gaming venue that expands the company’s route-based gaming network in another of its strongest growth […]
PlayStation Boss Says New Console Experiences Will Involve 'Leveraging Technologies That Can Be Used in Various Forms and Locations' — and I'm Convinced He's Teasing a PS6 Handheld
Recent comments from Sony Interactive Entertainment CEO Hideaki Nishino have suggested PlayStation may move towards more hybrid, Switch-like consoles in the future to match modern on-the-go players.
CORUS ENTERTAINMENT ANNOUNCES FISCAL 2026 THIRD QUARTER RESULTS
CorusEntertainmentInc. (TSX: CJR.B) announced its third quarter financial results today.
Massachusetts marijuana legalization repeal question battle heats up
Cannabis industry leaders are urging businesses to take the initiative seriously after many previously dismissed its chances.
Commitment season looming as Ohio State staff awaits
The month of June has been a grind for Ohio State’s coaching staff. Position camps, recruiting visits, and still prioritizing their current roster, the Buckeyes have had zero time off… and that will soon change. Ryan Day and company set to be on vacation in the coming days for a well deserved break, that doesn’t […]
Tigers host the Astros on home losing streak
The Detroit Tigers are looking to stop their three-game home slide with a victory against the Houston Astros
What could be next for Gakpo?
Following the departure of Mohamed Salah, at least one more attacking signing is expected at Anfield this summer. Liverpool have already signed Victor Munoz from Osasuna for £34.5m and the pursuit of Yan Diomande is heating up. Talented teenager Rio Ngumoha is also set to play a more prominent role, while Florian Wirtz played off the left for Liverpool at times last season and is featuring there for Germany in the World Cup.
Former Illinois forward Ben Humrichous signs contract with Nets
Heading to Brooklyn.
Parasite Affecting 1 in 3 People Is a Serious Risk to Human Health, Scientists Warn
More needs to be done.
Clippers draft pick Narcisse Ngoy announces he will play at Auburn next year in unique draft-and-stash situation
It's Xbox's turn (again), as console prices keep going up
Microsoft announced a price hike for the Xbox Series consoles today, the third in little over a year. Effective August 1, the Xbox Series S, which launched in 2020 for $300, will cost $500 in the U.S. The Xbox Series X, which launched in 2020 at $500, will go for $800. This follows a round of PlayStation 5 price increases from Sony this spring, and a slow-motion increase for Nintendo’s Switch 2, which will kick in in the U.S. in September. (Mind you, there were also eight video game industry price hikes in six months of 2025). The chart up top shows the sudden ascent of console prices over the past year, a sudden surge in an already unusual hardware generation. Prices had been flat for years, now “up” is the new “flat.” Game console prices used to go down across the length of a console generation, but not this time around. Microsoft’s explanation for the new price hike today: We hoped another price increase would not be necessary, and we have spent the last several months working with suppliers on options. Unfortunately, console storage and memory prices have increased by more than 2.5x and we expect another doubling by the fall of 2027. The entire consumer electronics industry is struggling with the current components crisis, but the effects are particularly hard on consoles. Unlike phones, computers, speakers, and other consumer devices, consoles are typically not sold at a profit, but instead for less than they cost to make. This is an issue well beyond game consoles. Apple announced price hikes on its computers and tablets today as well. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: Brutal Bungie cuts Bungie laid off “most” of its Destiny development team and some developers who worked on Marathon, the newest game from the struggling Sony-owned studio. A WARN notice issued by Sony to Washington State, where Bungie is based, tallied cuts impacting 292 workers, effective next month. That’s strictly for Bungie/Sony jobs in Washington and wouldn’t account for any elsewhere. The video I clipped below shows the redacted list of Bungie cuts filed to Washington State officials. As you’ll see, I had to scroll for a while… In a note emailed to PlayStation workers and published online, PlayStation game studios chief Hermen Hulst offered the following explanation for these latest cuts at Bungie: This is painful news, especially for talented colleagues whose roles have been eliminated. This decision was made only after extensive discussion and careful consideration, and I want to provide some context on how we arrived here. Over the past several months, together with Bungie leadership, we reviewed the studio’s long-term direction, development priorities, resource needs, and role within our broader portfolio strategy. We explored multiple alternatives before concluding that a reduction was necessary to align the studio’s resources with its current priorities and long-term goals. In 2022, Sony bought Bungie for $3.7 billion. The studio’s marquee game, the multiplayer live service shooter Destiny 2 was losing popularity at the time. Its next game Marathon, released earlier this year, has been well-reviewed but had a slow start. Bungie is renowned for making great shooter games, and Destiny fans have mourned the wind-down of Destiny 2. They’ve also expressed bewilderment over reports that Destiny 3 is not, per Bloomberg, immediately in the cards.
Dems put on blast over poll that shows record-low patriotism in US: 'Tear our society apart'
Rep. Harriet Hageman raises alarm over Gallup poll showing just 17% of Americans were "very proud" of their country, a record low in 25 years.
Serious statin side effects on muscles are extremely rare, new research confirms
Scientists created a new tool to help doctors predict a patient’s risk of severe muscle problems from taking a statin.
Moore links Maryland primary to Mamdani-backed wins; analysts disagree
Gov. Wes Moore says Maryland’s primary election showed voters rejected the status quo, but political analysts say the results reflect a more complicated picture.
Jimmy Butler shares ACL rehab update, expectations for Warriors next season
Jimmy Butler shared an encouraging update on his ACL injury rehab and his expectations for the Golden State Warriors in the 2026-27 NBA season.
Justices Clash on Whether Race Played a Role in Trump’s Bid to Deport Haitians
The split mirrored one that has long divided Americans: how seriously to take the president’s loose, provocative and sometimes ugly remarks.
Two Steelers land on CBS Sports Pete Prisco’s Top-100 NFL players list
A couple of Pittsburgh’s defensive stalwarts cracked the list.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Entrepreneurs pitched business ideas to Yahoo Finance
Yahoo Finance Executive Editor Brian Sozzi is on the hunt for the next big business breakthrough. Check out the absolute best pitches and standout moments from the innovators making waves at Cannes Lions.
Dating Coach Urges All Men to Avoid 'Worst' Hobby for Single Guys
A professional dating coach isn't holding back on the "F" tier hobby for single men in the United States. Blaine Anderson, a former travel industry worker who built a successful dating coach business,...
JD Sports Upgrades Listing to Broaden U.S. Investor Access
Shares of JD Sports in the U.S. now trade on the OTCQX exchange from the Pink Limited Market, broadening its access to deeper capital pools.
Commitment: Texas lands 2027 three-star IOL Lucas Rhoa
The Texas Longhorns continue a great week of recruiting by landing 2027 three-star interior offensive lineman Lucas Rhoa.
Oregon Ducks' DL dominates EA College Football 27 ratings
The ratings for top defensive linemen in EA Sports College Football 27 came out, and they're littered with Oregon Ducks.
Extreme heat and health: Policy guide reveals what communities need to know
Blistering temperatures exacerbated by high humidity are not just uncomfortable but dangerous. Across Canada, and in communities throughout southwestern Ontario, rising temperatures are affecting people's ...
Gillings-supported center helps public health teams prioritize infectious disease risks, from measles to the World Cup - UNC Gillings School of Global Public Health
June 25, 2026 When public health workers prepare for infectious disease threats, the question is rarely whether risk exists. It is where to focus first.
MIT in the media: Exploring how curiosity-driven science is an essential ingredient in America’s success
“Scientific American” showcases the history and future of America’s scientific engine, highlighting promising young scientists and icons at MIT and beyond.
ServiceNow: An Excellent Business Trading at a Discount
ServiceNow is doing everything right, and its stock price should begin to reflect that fact.
Psychedelic Science 2027 Speaker Submission Invites the Field to Bridge Promise and Practice
Psychedelic Science 2027 (PS27) convenes May 3–7, 2027, at the Colorado Convention Center in Denver under the theme “Bridging Promise & Practice”PS27’s speaker submission is now open through Friday, September 18, with no planned extensionsPS27 welcomes proposals across science, therapy, policy, culture, industry, the humanities, spirituality, connected movements, and the wisdom traditions that have carried this work for generations DENVER, June 25, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary
Gators among top-20 rated teams in EA Sports College Football 27
EA Sports views Florida as one of the nation's 25-best teams entering the 2026 season, so where exactly did the Gators land in CFB 27 rankings?
Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Split
NEW YORK, NY / ACCESS Newswire / June 25, 2026 / Paranovus Entertainment Technology Limited (NASDAQ:PAVS) ("we" or the "Company"), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.000012 ...
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
The Fourth Expedition
ARC Raiders is a multiplayer extraction adventure, set in a lethal future earth, ravaged by a mysterious mechanized threat known as ARC.
Experienced Vikings Executive Says Goodbye
The termination of Kwesi Adofo-Mensah in January has led to an avalanche of front office changes in the Twin Cities. […]
Kustom Entertainment Announces $5.5 Million Divestiture of Legacy Video Solutions Division to Cycurion, Advancing Live Entertainment Focus
Kustom Entertainment announces divestiture of video solutions division to Cycurion, enhancing focus on live events and ticketing.Quiver AI SummaryKustom Entertainment, Inc. announced a binding agreement to sell its legacy video solutions division to Cycurion, Inc., in a deal worth up to $5.5 million, including $1.25 million in cash and a $4.25 million promissory note. The transaction, expected to close in July 2026, will provide Kustom with finan
KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT
Transaction Structured to Provide Up to $5.5 Million plus 2,000,000 Warrants to acquire shares of common stock of Cycurion, Inc.; Follows Previously Announced Major Live Music Expansion Partnership with Gilley’s Park City OVERLAND PARK, KS, June 25, 2026 (GLOBE NEWSWIRE) -- Kustom Entertainment, Inc. (Nasdaq: KUST) (the “Company”), a live entertainment and music festival company, today announced it has entered into a binding agreement for the divestiture of its legacy video solutions division to
KUSTOM ENTERTAINMENT, INC. ANNOUNCES BINDING AGREEMENT FOR THE DIVESTITURE OF ITS VIDEO SOLUTIONS SEGMENT TO FULLY COMPLETE LIVE ENTERTAINMENT PIVOT
Transaction Structured to Provide Up to $5.5 Million plus 2,000,000 Warrants to acquire shares of common stock of Cycurion, Inc.; Follows Previously...
Moderna Science Day Highlights Expanding Potential of mRNA Platform
Provides broad overview of Company's research and early development programs expected to continue to fuel future growth Highlights validation of T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of second T-cell ...
AMC Entertainment Holdings, Inc. Announces Closing of $200 Million Registered Direct Offering of Common Stock
LEAWOOD, Kan., June 25, 2026--AMC Entertainment Holdings, Inc. (NYSE: AMC) ("AMC" or "the Company"), announced today that it closed its previously announced registered direct offering of an aggregate of 95,250,000 shares of AMC common stock for gross proceeds of approximately $200 million (the "Offering"), before deducting agent fees and offering expenses.
Vote in our L.A. Sports Hall of Fame (other sports edition)
Introducing the L.A. Times Sports Report Hall of Fame, where readers vote for Hall of Famers in various categories.
Mackenzie eyes UFC dream after Cage Warriors deal
Welsh bantamweight Ieuan Mackenzie is aiming to reach the UFC after signing a five-fight deal with Cage Warriors.
Pinky’s restaurant owner inks distribution deal for startup cheesecake business
“It’s a new challenge. I’m learning a whole new industry with something I’m familiar with, which is food,” said Steve DeRaffele, who launched Rio Cheesecakes earlier this year.
NFL insider thinks Commanders have some questions about Brandon Aiyuk
Washington Commanders: Don't pencil in Brandon Aiyuk to DC yet says Adam Schefter.
Mookie Betts continues resurgent streak with 300th career homer in Dodgers win
Mets trading David Peterson signals major deadline reset
David Peterson was the first domino for Mets.
NBA Draft Round 2 winners and losers: LaMelo Ball on the move? Must the Celtics trade Jaylen Brown? And players were drafted as well?
Betts homers for No. 300, Ohtani dominates after early trouble
MINNEAPOLIS — For a brief moment Wednesday night at Target Field, Shohei Ohtani looked vulnerable.
Latest COVID booster may offer bonus health benefit, study suggests
The latest COVID-19 vaccine (2024-2025) has been linked to fewer serious heart-related events among U.S. veterans. New research confirmed a small reduction in COVID-related cardiovascular events, or COVID-19-associated MACE, due to the vaccine.
‘America is back’: Trump kicks off Great American State Fair with flyovers, patriotic National Mall speech
Trump kicks off the Great American State Fair on the National Mall, comparing his political movement to the American Revolution at the 250th anniversary.
In 3-game healthcare series, underdog large-language models sweep specialized AI powerhouses
Pitting three multipurpose LLMs against two healthcare-specific AI tools, researchers have discovered the consumer-level AI can beat its purpose-built counterparts in healthcare scenarios—and soundly, at that.
NBA Draft: Knicks continue spate of trades, deal No. 31 and 55 picks to Rockets after moving out of first round
Mamdani's sweep in New York a 'political earthquake' among Democrats
New York City Mayor Zohran Mamdani scored a massive political victory on Tuesday when his trio of insurgent congressional candidates toppled two incumbents and the establishment favorite in an open seat, results some described as "a political earthquake" for Democrats.
The Red Sox Have a Big Jarren Duran Problem
The Boston Red Sox could have a tough time selling off one of their most obvious trade chips at this year's deadline.
By Refusing to Sign a Bipartisan Housing Bill, Trump Made It Clear That He Doesn’t Care About Everyday Americans
What’s the president’s priority instead? Passing his voter-suppressing SAVE Act to keep his cronies in power.
What Does Success Look Like in 2026 for Dolphins?
After moving on from veterans such as Tua Tagovailoa and Tyreek Hill, the upcoming season is about developing the Dolphins' roster, resetting the culture, and gaining salary cap flexibility for the future. The goal for any NFL team is not just to succeed in the immediate future but to establish a solid foundation for long-term success. After releasing Tagovailoa, Willis became the Dolphins' most significant free agent acquisition after he signed a three-year, $67.5 million contract with $45 million guaranteed.
Patriots Coach Jeremy Springer Announces Engagement To NBC Sports Host Kayla Burton
NBC Sports host Kayla Burton is engaged to an NFL coach. The popular Boston-based sports media personality announced her engagement to New England Patriots special teams coordinator Jeremy Springer. The two announced their big news in a joint Instagram post Monday, sharing photos from the NFL ...
US public health agency concludes hantavirus response as outbreak eases
The US Department of Health and Human Services has announced the end of the monitoring period for the virus.
Alex Rodriguez on how to build a business empire and what an MLB strike would mean to baseball
Baseball star Alex Rodriguez started building his business with a single $250,000 investment in 1995.
A-Rod talks his journey through the 'two B's': Baseball & Business
Former MLB All-Star and A-Rod Corp CEO Alex Rodriguez sits down with Yahoo Finance Executive Editor Brian Sozzi at the 2026 Cannes Lions International Festival of Creativity to discuss his upbringing and personal journeys through baseball and his ventures off the field in the world of business.
‘All My Children’ Alum’s Mysterious Health Crisis Prompts Plea From Friends and Costars
Marcy Walker is leaning on her All My Children and Santa Barbara family as she battles a private health issue. The 64-year-old former soap star’s friends, Melissa Braverman and Johanna Humphries, laun...
Scientists seek clues to longevity from three Brazilian sisters over 100
What is the secret to a long life? Three Brazilian sisters with a combined age of 316, who were named by Guinness this month as the oldest living trio of siblings in the world, may help researchers find out.
In failing to address Pride Night controversy, Giants' Buster Posey risks tarnishing his once untouchable legacy
“Cats go wild for this mysterious sound”—why experts say it works every time - Futura-Sciences
The Secret Behind the Slow Blink Cats are famous for their independent streak, but behind that mysterious gaze is a much more complex reality. Our feline friends are constantly seeking ways to communicate with us, but we humans aren’t always the best at picking up their signals. Scientific research has...
What does CBS Sports think is the best case scenario for the Vikings?
The Vikings season could go one of two ways, what does CBS Sports think is the good way?
Julian Edelman's blunt advice for Patriots with Christian Gonzalez
Julian Edelman shared his thoughts on the ongoing contract situation between the Patriots and star cornerback Christian Gonzalez.
Riot now lets you enable its anti-cheat when you want to
You’ll be able to turn on Vanguard just while you’re playing.
Dallas Cowboys 2026 training camp schedule released
We officially have a Dallas Cowboys training camp schedule.
The most controversial fossil site in human evolution just got even more puzzling
Scientists studied the remains of a mysterious human relative called Homo naledi found deep in a South African cave and determined they were all female.
China's Einstein Probe detected a mysterious cosmic explosion — and scientists have no idea what caused it
The explosion, consisting of two mysterious double flares, matches no known space eruption.
Creators are rethinking the exit
Founders like Clea Shearer, Hoda Kotb and Mel Robbins are prioritizing control.
As Blockbusters Loom, Monkey Business at the Supreme Court
An unlikely trio of justices issued a slashing critique of plea bargains that included several references to orangutans.
Trio behind string of business burglaries caught after chase through Tucker
Police said the suspects threw cash register tills and other stolen items from the vehicle.
Affordability, not fraud, is why fewer Americans have health insurance
The “fraud, waste, and abuse” narrative has been seriously overworked, and does not fit the facts.
What Are Colts' Best and Worst-Case Scenarios in 2026?
It's apparent that the Indianapolis Colts' success in 2026 lies heavily on quarterback Daniel Jones' shoulders.
Patriots links 6/24/26: Under-the-radar breakout prospects
Daily news and links for Wednesday
BYD's Stella Li talks expanding the business and home robots (with editor-in-chief Jamie Heller)
Entertainment Listing: June 24
Wednesday June 24 Little Nashville • Marion Bingo, 6 p.m. – 9 p.m. PK’s • Carbondale Trivia, 8 p.m. – 11 p.m. Advertisement Thursday June 25 PK’s • Carbondale Ethan Stephenson Band, 9 p.m. Little Nashville • Marion Chris Chamness, 6 p.m. – 9 p.m. Sunset Concert, New Era Events Plaza The Way Down...
Zohran Mamdani has lost none of his political magic
The New York Knicks might have won in five, but the city’s mayor did it in three: a trio of candidates backed by Mamdani appear set to land seats in US Congress
Political earthquake: 5 key takeaways from New York’s Democratic primaries
A trio of progressive insurgents backed by New York City Mayor Zohran Mamdani claimed victories in House primaries. Here’s what to know.
How wearable tech aims to innovate women's health care
Clair Health co-founder and CTO (Chief Technology Officer) Abhinav Agarwal comes on Asking for a Trend to explain how the company is using AI models in its hormone monitoring device and how new doctors, specifically OBGYNs, can use it to learn more.
Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
By Dennis Thompson HealthDay ReporterWEDNESDAY, June 24, 2026 (HealthDay News) — Want to give your baby the best start in life? Then tend to your heart health, both prior to and during pregnancy, a new study says. Expectant mothers in worse heart health are more likely to have children who suffer ...
Apple aims for better and more entertainment offerings, executive Cue says
Apple aims to release "better and more" TV shows and movies on its streaming service and in movie theaters, senior executive Eddy Cue told Reuters as he accepted an entertainment industry honor in France.
Bengals News (6/24): Will Cincinnati have Patriots-like turnaround?
A favorable schedule helped the Patriots make a historic turnaround.
After clashes, Senate Republicans prepare to talk it out with Trump
Trump’s relationship with some members has deteriorated — not least because he helped to defeat two of them in GOP primaries.
Report: Pacers Targeting Guard in Second Round of NBA Draft
The Indiana Pacers are reportedly targeting an intriguing guard in the second round of the 2026 NBA Draft.
Pro-Israel politics just took a huge hit in New York
Progressives critical of Israel swept a trio of House races in the home of the nation’s largest Jewish population — a stunning shift that carries national implications for the party.
Jeremy Clarkson's health dilemma 'common among farmers'
The TV star shared his worried treatment would overlap with a busy period for his Cotswolds farm.
Predicting the Nets 2026-27 Opening Night Starting Lineup
In the aftermath of the 2026 NBA Draft and a big trade, how do the Nets look heading into next season?
The Grand Seiko Evolution 9 Spring Drive U.F.A. Models Get Serious Fan-Requested Updates
✓ Grand Seiko Evolution 9 gets five Spring Drive U.F.A. models ✓ New 9RB2 accuracy, materials, and clasp ✓ See them here
Bills legend Jim Kelly reveals he suffered stroke this spring
A Hall of Fame quarterback revealed he dealt with a health scare recently.
Vistra Expands Latin American Business Reach
The launch follows the group's acquisition of a Latam business late in 2025.
Race, politics fueled airport takeover effort, Jackson Mayor Horhn testifies
Jackson Mayor John Horhn was the second witness called in Day 2 of Jackson's airport takeover trial.
Want to feel happier at work? Take a five-minute walk
Sitting for prolonged periods is associated with health complications – but you can counteract the risks of a sedentary life.
Bunnie Xo Was ‘Seriously Considering a Return’ to Adult Entertainment Before Jelly Roll Split
Jelly Roll and Bunnie Xo‘s divorce news made headlines earlier this month, and a new report says that her desire to return to the world of adult entertainment played a part in their decision to part w...
Angels Haunted by Trades in Loss to Orioles
Two past trade deals came back to haunt the Los Angeles Angels during the series opener against the Baltimore Orioles on Monday. The Angels lost 6-1 to the Orioles, with two of the Halos’ former players shining during the game. In the first inning, former Angels outfielder Taylor Ward hit a leadoff home run to […] The post Angels Haunted by Trades in Loss to Orioles appeared first on LA Sports Report.